Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis

Figure 3 Effects of partially hydrolyzed guar gum on lipid synthesis and degradation in the non-alcoholic fatty liver disease model. A: Acetyl-CoA carboxylase; B: Carnitine O-palmitoyltransferase II; C: Peroxisome proliferator-activated receptor (PPAR) α; D: PPARγ mRNA expression in the liver. mRNA expression was evaluated using real-time polymerase chain reaction. Data represent the mean ± SD of seven mice. ^aP < 0.05 significant differences compared to the control group. NAFLD: Non-alcoholic fatty liver disease; PHGG: Partially hydrolyzed guar gum; ACC: Acetyl-CoA carboxylase; PPAR: Peroxisome proliferator-activated receptor; CPT2: Carnitine O-palmitoyltransferase II.